Related Articles
Pterostilbene increases PTEN expression through the targeted downregulation of microRNA-19a in hepatocellular carcinoma
The blueberry component pterostilbene has potent anti-myeloma activity in bortezomib-resistant cells
Pterostilbene inhibits hepatocellular carcinoma through p53/SOD2/ROS-mediated mitochondrial apoptosis
Pterostilbene protects against acute renal ischemia reperfusion injury and inhibits oxidative stress, inducible nitric oxide synthase expression and inflammation in rats via the Toll‑like receptor 4/nuclear factor‑κB signaling pathway
Pterostilbene attenuates acute kidney injury in septic mice